Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001103780-16-000093

CEO bought 5,100 shares at $0.13 ($653)

From the SEC's structured data for this filing

Trades in this filing

BUNKA CHRISTOPHER · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-08-26 Purchase : show line 1 in the form +5,100 $0.13 $653 7,213,079 D
Open-market purchases · 5,100 sh · avg $0.13 · $653
Loading xslF345X03/primary_doc.xml…